PYXS vs SGEN
Pyxis Oncology Inc (PYXS) versus SGEN (SGEN) — a side-by-side from cached financials, not a winner call.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
SGEN (SGEN) common stock.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
SGEN does not have a complete income-statement cache yet.
PYXS currently screens at market cap $109.6M.
Not investment advice. Open the PYXS and SGEN stock pages for the full models.
Not investment advice.